2024年度跟踪报告 | 保荐人名称：中信证券股份有限公司 | 被保荐公司简称：凌玮科技 | | --- | --- | | 保荐代表人姓名：蒋向 | 联系电话：020-32258161 | | 保荐代表人姓名：廖俊民 | 联系电话：020-32259103 | 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 1.公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 无 | | 2．督导公司建立健全并有效执行规章制度的情况 | | | （1）是否督导公司建立健全规章制度（包括但不 限于防止关联方占用公司资源的制度、募集资金 | 是 | | 管理制度、内控制度、内部审计制度、关联交易 | | | 制度） | | | （2）公司是否有效执行相关规章制度 | 是，根据凌玮科技2024年度内部控制自我评价 | | | 报告，发行人有效执行了相关规章制度 | | 3.募集资金监督情况 | | | （1）查询公司募集资金专户次数 | 12次 | | （2）公司募集资金项目进展是否与信息披露文件 | 是 | | 一致 ...

Core Viewpoint - The company has approved the conclusion of certain fundraising projects and the permanent allocation of surplus funds to enhance operational efficiency and meet daily operational needs [22][38][41]. Financial Data - The company reported a total fundraising amount of 914.76 million yuan, with a net amount of 820.73 million yuan after deducting issuance costs [23][30]. - The surplus funds from the project "Annual Increase of 20,000 Tons of Ultra-fine Silica Aerogel Series Products" amount to 9.84 million yuan, which will be permanently allocated to supplement working capital [22][37]. Board and Supervisory Committee Decisions - The board of directors unanimously approved the first-quarter report and the proposal to allocate surplus funds, confirming that the report accurately reflects the company's financial status [12][18]. - The supervisory committee also approved the same proposal, emphasizing that it aligns with the interests of all shareholders and complies with relevant regulations [19][39]. Project Completion and Fund Allocation - The project "Annual Increase of 20,000 Tons of Ultra-fine Silica Aerogel Series Products" has reached a usable state, meeting the conditions for project completion [24][38]. - The decision to allocate surplus funds is based on effective cost management during the project, which resulted in lower expenses [36][37]. Regulatory Compliance - The company has adhered to the necessary regulatory requirements for the allocation of surplus funds, ensuring that there is no detriment to the interests of shareholders [41][42].

证券代码：301373 证券简称：凌玮科技 公告编号：2025-57 广州凌玮科技股份有限公司 第四届监事会第三次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 经核查，监事会认为：公司《2025 年第一季度报告》真实反映了公司的财 务状况和经营成果，符合法律、行政法规、中国证监会和深圳证券交易所的相关 规定，报告内容真实、准确、完整，不存在任何虚假记载、误导性陈述或者重大 遗漏。 具 体 内 容 详 见 公 司 于 同 日 刊 登 在 指 定 信 息 披 露 媒 体 巨 潮 资 讯 网 （www.cninfo.com.cn）的《2025 年第一季度报告》。 （二）会议以 3 票同意、0 票反对、0 票弃权的表决结果，审议通过了《关 于部分募投项目结项并将节余募集资金永久补充流动资金的议案》。 1 一、监事会会议召开情况 广州凌玮科技股份有限公司（以下简称"公司"）第四届监事会第三次会议 通知于 2025 年 4 月 21 日以电子邮件、微信通知等方式发出，并于 2025 年 4 月 23 日在公司总部大会议室以现场结合通讯方式召开。本次会议由监 ...

证券代码：301373 证券简称：凌玮科技 公告编号：2025-56 广州凌玮科技股份有限公司 第四届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 广州凌玮科技股份有限公司（以下简称"公司"）第四届董事会第三次会议 通知已于 2025 年 4 月 21 日以电子邮件、微信通知等方式发出，并于 2025 年 4 月 23 日在公司总部大会议室以现场结合通讯方式召开。本次会议由董事长胡颖 妮女士召集和主持，应到董事 7 人，实到董事 7 人，公司监事、高级管理人员列 席本次会议。本次会议的召集、召开和表决符合《公司法》《证券法》等有关法 律、行政法规、部门规章、规范性文件和《公司章程》的有关规定，会议合法、 有效。 二、董事会会议审议情况 经与会董事认真审议，形成如下决议： （一）会议以 7 票同意、0 票反对、0 票弃权的表决结果，审议通过《2025 年第一季度报告》。 经审议，董事会认为：公司《2025 年第一季度报告》真实反映了公司的财 务状况和经营成果，符合法律、行政法规、中国证监会和深圳证券交易所的相关 ...

中信证券股份有限公司 关于广州凌玮科技股份有限公司 部分募投项目结项并将节余募集资金永久补充流动资金的核 查意见 中信证券股份有限公司（以下简称"中信证券"或"保荐人"）作为广州凌 玮科技股份有限公司（以下简称"凌玮科技""公司"或"发行人"）首次公开发 行股票并在创业板上市的保荐人和主承销商，根据《证券发行上市保荐业务管理 办法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范 运作（2023 年 12 月修订）》《上市公司监管指引第 2 号——上市公司募集资金管 理和使用的监管要求（2022 年修订）》等相关规定，对凌玮科技部分募投项目结 项并将节余募集资金永久补充流动资金的事项进行了核查。核查的具体情况及核 查意见如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意广州凌玮科技股份有限公司首次公开 发行股票的批复》（证监许可〔2022〕2253 号）核准，公司首次公开发行人民币 普通股（A 股）2,712.00 万股，发行价格为 33.73 元/股，募集资金总额 914,757,600.00 元，扣除不含税的发行费用 94,030,758.27 元后，实际募集资金净 额为 ...

Group 1 - The core point of the article is that Lingwei Technology (301373) reported its Q1 2025 revenue and net profit, showing positive growth compared to the previous year [1] Group 2 - The revenue for Q1 2025 reached 110 million yuan, representing an 8.34% year-on-year increase [1] - The net profit for the same period was 31.4286 million yuan, reflecting a 6.41% year-on-year growth [1]

Financial Performance - The company's revenue for Q1 2025 reached ¥109,583,251.92, representing an increase of 8.34% compared to ¥101,152,000.27 in the same period last year[5] - Net profit attributable to shareholders was ¥31,428,645.83, up 6.41% from ¥29,534,549.09 year-on-year[5] - Basic and diluted earnings per share increased by 7.41% to ¥0.29 from ¥0.27 in the previous year[5] - Total operating revenue for the current period reached ¥109,583,251.92, an increase of 8.6% compared to ¥101,152,000.27 in the previous period[25] - Net profit for the current period was ¥31,453,276.21, representing a growth of 6.3% from ¥29,584,628.18 in the prior period[26] - The total comprehensive income for the period was CNY 31,453,276.21, an increase from CNY 29,584,628.18 in the previous period, representing a growth of approximately 6.3%[27] Assets and Equity - Total assets as of March 31, 2025, were ¥1,770,795,871.22, a slight increase of 0.47% from ¥1,762,572,068.68 at the end of the previous year[5] - The company's total assets increased to ¥1,770,795,871.22, compared to ¥1,762,572,068.68, marking a growth of 0.9%[22] - The company’s total equity attributable to shareholders increased by 1.96% to ¥1,631,522,895.07 from ¥1,600,094,249.24 at the end of the previous year[5] - The total equity attributable to shareholders rose to ¥1,631,522,895.07, up from ¥1,600,094,249.24, reflecting a growth of 1.9%[23] Cash Flow - The net cash flow from operating activities decreased significantly by 57.65%, amounting to ¥8,374,275.41 compared to ¥19,776,153.75 in Q1 2024[13] - The company's cash and cash equivalents saw a net decrease of ¥78,576,544.51, a decline of 290.61% compared to an increase of ¥41,223,360.76 in the same period last year[13] - The cash balance at the end of the reporting period is ¥263,863,003.37, down from ¥341,801,119.10 at the beginning of the period[20] - Cash inflow from investment activities totaled CNY 505,320,329.41, compared to CNY 466,718,452.72 in the previous period, marking an increase of about 8.5%[30] - The net cash flow from investment activities was negative at CNY -85,928,412.88, a significant decrease from CNY 22,342,807.58 in the prior period[30] - The ending balance of cash and cash equivalents was CNY 261,030,946.62, down from CNY 491,663,174.93, a decrease of approximately 46.8%[31] Shareholder Information - The total number of common shareholders at the end of the reporting period is 10,332[15] - The largest shareholder, Hu Yingni, holds 46.79% of the shares, totaling 50,755,565 shares[15] - The second-largest shareholder, Xinyu Gaoling Investment Partnership, holds 6.45% with 7,000,000 shares[15] - The company has a total of 69,999,268 restricted shares, with the majority set to be released on August 8, 2026[18] - The company has a significant number of shares held by insiders, with Hu Yingni and Hu Xiangzhong being the actual controllers[16] - The top ten unrestricted shareholders include Shenzhen Lingxin Jicheng Investment Fund Management with 5,041,393 shares[16] - The company has a total of 1,916,700 shares held by shareholder Xie Yangchu, indicating active participation in the market[16] - The company has not reported any changes in the top ten shareholders due to securities lending[17] - The company maintains a strong insider ownership structure, with several shareholders holding significant stakes[16] Costs and Expenses - Total operating costs amounted to ¥76,762,623.04, up from ¥69,081,494.15, reflecting a rise of 11.5%[25] - Research and development expenses were recorded at ¥6,428,030.09, slightly down from ¥7,093,046.21, indicating a focus on cost management[26] - The company reported a significant increase in tax and additional charges, which rose by 103.82% to ¥1,015,364.04 compared to ¥498,176.45 in Q1 2024[11] - The company paid CNY 13,487,611.60 in taxes, which is an increase from CNY 7,945,664.49, representing a rise of approximately 69.5%[30] - The company received CNY 2,557,846.60 in tax refunds, slightly up from CNY 2,553,412.37 in the previous period[30] Investment Income - The company reported a significant increase in investment income, which rose by 87.12% to ¥3,215,588.04 from ¥1,718,452.72 in Q1 2024[11] - The company reported an investment income of ¥3,215,588.04, which is a substantial increase from ¥1,718,452.72 in the previous period[26] Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[24]

证券代码：301373 证券简称：凌玮科技 公告编号：2025-59 广州凌玮科技股份有限公司 关于部分募投项目结项并将节余募集资金 永久补充流动资金的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 2025 年 4 月 23 日，广州凌玮科技股份有限公司（以下简称"凌玮科技"或 "公司"）分别召开第四届董事会第三次会议及第四届监事会第三次会议，审议 通过了《关于部分募投项目结项并将节余募集资金永久补充流动资金的议案》， 公司首次公开发行股票募集资金投资项目中"年新增 2 万吨超细二氧化硅气凝胶 系列产品项目"已达到预定可使用状态，满足结项条件，并存在部分节余募集资 金。为提高募集资金的使用效率，避免资金长期闲置，同意公司将上述募投项目 结项后的节余募集资金 984.18 万元（实际金额以资金转出当日专户余额为准） 永久补充流动资金，用于公司日常生产经营。上述事项在公司董事会审批权限范 围内，无需提交公司股东大会审议。保荐机构中信证券股份有限公司对此出具明 确的核查意见。现将相关情况公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于同意广州 ...

审计报告 广州凌玮科技股份有限公司 容诚审字[2025]518Z0890 号 容诚会计师事务所(特殊普通合伙) 中国·北京 目 录 | 序号 | 内 容 | 页码 | | --- | --- | --- | | 1 | 审计报告 | 1-6 | | 2 | 合并资产负债表 | 1 | | 3 | 合并利润表 | 2 | | 4 | 合并现金流量表 | 3 | | 5 | 合并所有者权益变动表 | 4-5 | | 6 | 母公司资产负债表 | 6 | | 7 | 母公司利润表 | 7 | | 8 | 母公司现金流量表 | 8 | | 9 | 母公司所有者权益变动表 | 9-10 | | 10 | 财务报表附注 | 11-111 | 审 计 报 告 容诚会计师事务所(特殊普通合伙) 总所：北京市西城区阜成门外大街 22 号 1 幢 10 层 1001-1 至 1001-26 (100037) TEL:010-6600 1391 FAX:010-6600 1392 E-mail:bj@rsmchina.com.cn https//WWW.rsm.global/china/ 容诚审字[2025]518Z0890 号 ...

容诚会计师事务所（特殊普通合伙） 总所：北京市西城区阜成门外大街 22 号 1 幢 10 层 1001-1 至 1001-26 (100037) TEL:010-6600 1391 FAX:010-6600 1392 E-mail:bj@rsmchina.com.cn https://www.rsm.global/china/ 内部控制审计报告 容诚审字[2025]518Z0891 号 广州凌玮科技股份有限公司全体股东： 按照《企业内部控制审计指引》及中国注册会计师执业准则的相关要求，我 们审计了广州凌玮科技股份有限公司（以下简称"凌玮科技公司"）2024 年 12 月 31 日的财务报告内部控制的有效性。 内部控制审计报告 广州凌玮科技股份有限公司 容诚审字[2025]518Z0891 号 容诚会计师事务所(特殊普通合伙) 中国·北京 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企业内部 控制评价指引》的规定，建立健全和有效实施内部控制，并评价其有效性是凌玮 科技公司董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上，对财务报告内部控制的有效性发 ...